Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Technology

LM Funding America reports revenue growth amid Bitcoin volatility and infrastructure expansion

LM Funding America (NASDAQ:LMFA), a cryptocurrency mining and specialty finance company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: LM Funding America reports revenue growth amid Bitcoin volatility and infrastructure expansion
Grafa

BioXcel Therapeutics advances toward home-use approval for IGALMI following 2025 financial results

BioXcel Therapeutics (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: BioXcel Therapeutics advances toward home-use approval for IGALMI following 2025 financial results
Grafa

Instil Bio shifts to external innovation strategy following discontinuation of lead asset

Instil Bio (NASDAQ:TIL), a clinical-stage biopharmaceutical company, today reported its financial results for the fourth quarter and full year ended December 31, 2025, while outlining a transformative shift in its corporate strategy.

Leia mais: Instil Bio shifts to external innovation strategy following discontinuation of lead asset
Grafa

AstraZeneca’s Tozorakimab delivers milestone Phase III victory in broad COPD population

AstraZeneca (NASDAQ:AZN) today announced positive high-level results from the OBERON and TITANIA Phase III trials, marking a historic milestone in the treatment of chronic obstructive pulmonary disease (COPD).

Leia mais: AstraZeneca’s Tozorakimab delivers milestone Phase III victory in broad COPD population
Grafa
Technology

Legence shares soar as 2025 revenue hits $2.5B on surging decarbonization demand

Legence (NASDAQ:LGN), a preeminent integrated provider of energy efficiency and sustainability solutions for the built environment, today reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: Legence shares soar as 2025 revenue hits $2.5B on surging decarbonization demand
Grafa
Health

SBC Medical Group reports 117% surge in Q4 net income despite revenue headwinds

SBC Medical Group Holdings (NASDAQ:SBC), a leading Management Services Organization (MSO) for a diverse range of medical franchises, today announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025.

Leia mais: SBC Medical Group reports 117% surge in Q4 net income despite revenue headwinds
Grafa

FDA approves Novo Nordisk’s Awiqli as first once-weekly basal insulin for type 2 diabetes

Novo Nordisk (NYSE:NVO) today announced that the U.S. Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae), the first and only once-weekly, long-acting basal insulin for adults living with type 2 diabetes.

Leia mais: FDA approves Novo Nordisk’s Awiqli as first once-weekly basal insulin for type 2 diabetes